Literature DB >> 34311389

Qualitative coronary artery calcification scores and risk of all cause, COPD and pneumonia hospital admission in a large CT lung cancer screening cohort.

Lee Gazourian1, Shawn M Regis2, Elizabeth J Pagura3, Lori Lyn Price4, Melissa Gawlik5, Carla Lamb6, Kimberly M Rieger-Christ7, William B Thedinger8, Ava M Sanayei8, William P Long8, Cristina F Stefanescu9, Giulia S Rizzo10, Avignat S Patel6, Carolyn E Come6, Carey C Thomson11, Victor Pinto-Plata12, Katrina Steiling13, Andrea B McKee2, Christoph Wald14, Brady J McKee14, Timothy N Liesching6.   

Abstract

BACKGROUND: Patients at high-risk for lung cancer and qualified for CT lung cancer screening (CTLS) are at risk for numerous cardio-pulmonary comorbidities. We sought to examine if qualitatively assessed coronary artery calcifications (CAC) on CTLS exams could identify patients at increased risk for non-cardiovascular events such as all cause, COPD and pneumonia related hospitalization and to verify previously reported associations between CAC and mortality and cardiovascular events. STUDY DESIGN AND METHODS: Patients (n = 4673) from Lahey Hospital and Medical Center who underwent CTLS from January 12, 2012 through September 30, 2017 were included with clinical follow-up through September 30, 2019. CTLS exams were qualitatively scored for the presence and severity of CAC at the time of exam interpretation using a four point scale: none, mild, moderate, and marked. Multivariable Cox regression models were used to evaluate the association between CT qualitative CAC and all-cause, COPD-related, and pneumonia-related hospital admissions.
RESULTS: 3631 (78%) of individuals undergoing CTLS had some degree of CAC on their baseline exam: 1308 (28.0%), 1128 (24.1%), and 1195 (25.6%) had mild, moderate and marked coronary calcification, respectively. Marked CAC was associated with all-cause hospital admission and pneumonia related admissions HR 1.48; 95% CI 1.23-1.78 and HR 2.19; 95% 1.30-3.71, respectively. Mild, moderate and marked CAC were associated with COPD-related admission HR 2.30; 95% CI 1.31-4.03, HR 2.17; 95% CI 1.20-3.91 and HR 2.27; 95% CI 1.24-4.15.
CONCLUSION: Qualitative CAC on CTLS exams identifies individuals at elevated risk for all cause, pneumonia and COPD-related hospital admissions.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COPD; Coronary artery calcification; Lung cancer screening; Pneumonia

Mesh:

Year:  2021        PMID: 34311389      PMCID: PMC8579718          DOI: 10.1016/j.rmed.2021.106540

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   4.582


  28 in total

1.  Lung cancer screening.

Authors:  Douglas E Wood; George A Eapen; David S Ettinger; Lifang Hou; David Jackman; Ella Kazerooni; Donald Klippenstein; Rudy P Lackner; Lorriana Leard; Ann N C Leung; Pierre P Massion; Bryan F Meyers; Reginald F Munden; Gregory A Otterson; Kimberly Peairs; Sudhakar Pipavath; Christie Pratt-Pozo; Chakravarthy Reddy; Mary E Reid; Arnold J Rotter; Matthew B Schabath; Lecia V Sequist; Betty C Tong; William D Travis; Michael Unger; Stephen C Yang
Journal:  J Natl Compr Canc Netw       Date:  2012-02       Impact factor: 11.908

2.  C-reactive protein in patients with COPD, control smokers and non-smokers.

Authors:  V M Pinto-Plata; H Müllerova; J F Toso; M Feudjo-Tepie; J B Soriano; R S Vessey; B R Celli
Journal:  Thorax       Date:  2005-09-02       Impact factor: 9.139

3.  Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.

Authors:  Suellen M Curkendall; Cynthia DeLuise; Judith K Jones; Stephan Lanes; Mary Rose Stang; Earl Goehring; Dewei She
Journal:  Ann Epidemiol       Date:  2005-07-21       Impact factor: 3.797

4.  Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.

Authors:  Janaki A Deepak; Xinyi Ng; Josephine Feliciano; Li Mao; Amy J Davidoff
Journal:  Ann Am Thorac Soc       Date:  2015-05

Review 5.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

6.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

7.  Qualitative coronary artery calcium assessment on CT lung screening exam helps predict first cardiac events.

Authors:  Katherine B Malcolm; Danya L Dinwoodey; Michael C Cundiff; Shawn M Regis; Andrea K Borondy Kitts; Christoph Wald; Miranda L Lynch; Wael Al-Husami; Andrea B McKee; Brady J McKee
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

8.  Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Alex H Krist; Karina W Davidson; Carol M Mangione; Michael J Barry; Michael Cabana; Aaron B Caughey; Esa M Davis; Katrina E Donahue; Chyke A Doubeni; Martha Kubik; C Seth Landefeld; Li Li; Gbenga Ogedegbe; Douglas K Owens; Lori Pbert; Michael Silverstein; James Stevermer; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2021-03-09       Impact factor: 56.272

9.  Qualitative emphysema and risk of COPD hospitalization in a multicenter CT lung cancer screening cohort study.

Authors:  Lee Gazourian; William B Thedinger; Shawn M Regis; Elizabeth J Pagura; Lori Lyn Price; Melissa Gawlik; Cristina F Stefanescu; Carla Lamb; Kimberly M Rieger-Christ; Harpreet Singh; Marcel Casasola; Alexander R Walker; Arashdeep Rupal; Avignat S Patel; Carolyn E Come; Ava M Sanayei; William P Long; Giulia S Rizzo; Andrea B McKee; George R Washko; Raul San Jose Estepar; Christoph Wald; Brady J McKee; Carey C Thomson; Timothy N Liesching
Journal:  Respir Med       Date:  2020-11-20       Impact factor: 3.415

10.  Coronary artery calcium before and after hospitalization with pneumonia: The MESA study.

Authors:  Vicente F Corrales-Medina; Girish Dwivedi; Monica Taljaard; William Petrcich; Joao A Lima; Sachin Yende; Richard A Kronmal; Julio A Chirinos
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.